- Report
- August 2023
- 51 Pages
United Kingdom
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
China
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Switzerland
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Argentina
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Brazil
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Israel
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Colombia
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
India
From €543EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
South Africa
From €543EUR$600USD£469GBP
- Report
- April 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- December 2024
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- September 2024
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Training
- July 2026
- 3 Hours
Global
- Report
- October 2025
- 82 Pages
Vietnam
From €4393EUR$4,850USD£3,790GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4393EUR$4,850USD£3,790GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more